Mechanical thrombo-embolectomy in acute ischaemic stroke: A local experience

Cardiovascular Journal of Africa

Volumn 19, Issue 4, 2008, Pages 204-207

  Abelson, Mark ^a   Roos, Johan ^a   Rymer, Marilyn ^b  

^a Vergelegen Medi Clinic   (South Africa)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANAMNESIS; ARTICLE; BLOOD CLOT LYSIS; BRAIN ANGIOGRAPHY; CASE REPORT; DYSPHASIA; EMBOLECTOMY; FEMALE; HEMIPLEGIA; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MALE; REVASCULARIZATION; STROKE; TREATMENT RESPONSE;

AGED; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; EMBOLECTOMY; FATAL OUTCOME; FEMALE; HUMANS; MALE; MIDDLE AGED; STROKE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 51449102733     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Declaration statement. World International Stroke Congress, October 2007, Cape Town, South Africa.
2. Kleindorfer D, Kissela B, Schneider A, et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population based study. Stroke 2004; 35: 27e-29e.
3. The National Institute of Neurological Disorders and Stroke rt-PA Stroke study group tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
4. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36: 1432.
5. Smith WS, for the Multi Merci Investigators. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. Am J Neuroradiol 2006; 27(6): 1177-1182.
6. Bonita R, Beaglehole R. Modification of Rankin Scale: recovery of motor function after stroke. Stroke 1988; 19: 1497-1500.
7. Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke 2006; 37: 922.
8. Kwiatkowski T, Libman R, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med 1999; 340: 1781-1787.
9. Linfante I, Llinas RH, Selim M, et al. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke 2002; 33: 2066.
10. Saqqur M, Uchino K, Demchu, AM, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007; 38: 948.
11. Ribo, M, Alvarez-Sabin J, Montaner J, et al. Temporal profile of recanalization after intravenous tissue plasminogen activator. Stroke 2006; 37: 1000-1004.
12. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007; 38: 967.